Clinical Director, Department of Radiation Oncology, Massachusetts General Hospital
Radiation Oncology
Dr. Paul M. Busse, MD
|
|
Give Review
Paul Busse practices Radiation Oncology. He attended Saint Louis University School of Medicine. Saint Louis University School of Medicine has a rank of 67 in research and a 57 in primary care He over the years received 1 awards: "Super Doctor". Paul M. Busse, MD is also a published doctor. He has 51 paper published. The most recent paper is: Induction therapy for rectal carcinoma. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
- Bending the cost curve: a unique collaboration between radiation oncologists and blue cross blue shield of massachusetts to optimize the use of advanced technology.
- Addressing the Growing Cancer Burden in the Wake of the AIDS Epidemic in Botswana: The BOTSOGO Collaborative Partnership.
- Extensive basal cell carcinoma of the face: An extreme case of denial.
- Delayed complications after anterior craniofacial resection of malignant skull base tumors.
- Long-term survival after distant metastasis in patients with oropharyngeal cancer.
- Head and Neck Cancers, Version 2.2013.
- Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: Long-term dysphagia and tumor control outcomes.
- Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
- Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
- Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
- Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
- Functional and histological changes in rat lung after boron neutron capture therapy.
- Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma.
- Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
- Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.
- Pathology quiz case 1. Adenocarcinoma with features of mucinous adenocarcinoma (MAC) and cystadenocarcinoma (CAC).
- Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
- Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
- Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year foll...
- A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
- Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy.
- Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase ...
- A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
- An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.
- Induction therapy for rectal carcinoma.
- Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
- Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes.
- Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
- Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy.
- Sphincter preservation therapy for distal rectal carcinoma: a review.
- Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
- Primary site management following induction chemotherapy with cis-platinum, 5-fluorouracil, and leucovorin.
- Effect of combined modality therapy on the surgical management of locally advanced rectal carcinoma.
- Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer.
- Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and...
- The action of caffeine on X-irradiated HeLa cells. IV. Progression delays and enhanced cell killing at high caffeine concentrations.
- Synergistic killing of HeLa cells by hydroxyurea and caffeine.
- CT evaluation of local and regional breast cancer recurrence.
- Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience.
- Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
- Intraoperative radiation therapy for carcinoma of the gallbladder.
- The action of caffeine on X-irradiated HeLa cells. II. Synergistic lethality.
- The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis.
- The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest.
- Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
- Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of t...
- Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences.
- A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.
- The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.
Schools
Saint Louis University School Of Medicine
Barnes Jewish Hospital
Massachusetts General Hospital
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Super Doctor
Education
-
Massachusetts General Hospital -
Washington University - Barnes-Jewish Hospital -
Saint Louis University School of Medicine
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1073587291 | |
| NPPES Provider LastName | BUSSE | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 021142617 | |
| NPPES Provider State | MA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073587291 |
| Last Name Of The Provider | BUSSE |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Kevin S. Oh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hani Al-Halabi, MDCM |
|
|
Dr. Ann C. Raldow, MD |
|
|
Dr. Jonathan D. Schoenfeld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron M. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alec C. Kimmelman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart M. Berman, MD |
|
|
Dr. Jason A. Efstathiou, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anthony L. Zietman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Shital Makim, MD |